Next Article in Journal
Overview of Cellular and Soluble Mediators in Systemic Inflammation Associated with Non-Alcoholic Fatty Liver Disease
Next Article in Special Issue
Vascular Ageing: Mechanisms, Risk Factors, and Treatment Strategies
Previous Article in Journal
Cabozantinib, Vandetanib, Pralsetinib and Selpercatinib as Treatment for Progressed Medullary Thyroid Cancer with a Main Focus on Hypertension as Adverse Effect
 
 
Article

Article Versions Notes

Int. J. Mol. Sci. 2023, 24(3), 2314; https://doi.org/10.3390/ijms24032314
Action Date Notes Link
article pdf uploaded. 24 January 2023 14:01 CET Version of Record https://www.mdpi.com/1422-0067/24/3/2314/pdf-vor
article xml file uploaded 7 February 2023 07:07 CET Original file -
article xml uploaded. 7 February 2023 07:07 CET Update https://www.mdpi.com/1422-0067/24/3/2314/xml
article pdf uploaded. 7 February 2023 07:07 CET Updated version of record https://www.mdpi.com/1422-0067/24/3/2314/pdf
article supplementary file uploaded. 7 February 2023 07:07 CET - https://www.mdpi.com/1422-0067/24/3/2314#supplementary
article html file updated 7 February 2023 07:08 CET Original file -
article html file updated 8 March 2023 01:59 CET Update https://www.mdpi.com/1422-0067/24/3/2314/html
Back to TopTop